A pleasure catching up with our European Editorial Board member Stefan Evers (University of Münster, Germany). He spoke to us about miscellaneous idiopathic headache disorders, the topic of his presentation in the ‘Integrative Treatment of Idiopathic Headache Disorders’ session.
Questions
1. What is covered by the term ‘miscellaneous idiopathic headache disorders’? (0:05)
2. What are the guideline recommended treatments for these disorders? (0:40)
3. What are the major unmet needs in the treatment of miscellaneous idiopathic headache disorders? (1:23)
4. How can drug treatment and interventional treatment be integrated for patients with these disorders? (2:08)
5. Are there any emerging treatments for these disorders? (2:55)
Speaker disclosure: Stefan Evers reports having received honoraria for consultation and lectures over the last 3 years from Allergan, Eli Lilly, Novartis and Teva.
Support: Interview and filming supported by Touch Medical Media.
Filmed at the 6th Congress of the European Academy of Neurology (EAN) and 1st EAN Virtual Congress, May 2020.
